Barely Significant
← all excerpts

Central blood pressure lowering effect of telmisartan-rosuvastatin single-pill combination in hypertensive patients combined with dyslipidemia: A pilot study.

J Clin Hypertens (Greenwich) · 2021 · PMC8678791 · PMID 34384001

1
hedged sentence
closest p
boldest claim

The sentences

might be significantno p-value reported
We did not exclude the possibility that the difference might be significant if the original enrolment was completed (type 2 error).

also in 2,435 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.